Follow the STARPHARMA HOLDINGS LIMITED stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €345.9m. The latest transaction was disclosed on 24 August 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. All data is free.
12
Insider Decl.
n/a
Thresholds
€189,166
5 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Buys €189,166n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,597 of 28,929 companies
40.1
score / 100
Value
28
Quality
52
FCF yld-2.0%
Earn yld-2.9%
EV/EBITDA·
ROE-14%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
STARPHARMA HOLDINGS LIMITED is an Australian biopharmaceutical company focused on developing drugs based on its proprietary polymer technology. It targets treatments for cancer and viral infections.